A prospective cohort study for prognostic value of serum soluble LR11 in patients with acute leukemia and malignant lymphoma (LR11-study)

A prospective cohort study for prognostic value of serum soluble LR11 in patients with acute leukemia and malignant lymphoma (LR11-study) - LR11-study in acute leukemia and malignant lymphoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004032

Enrollment

240

Registered

2010-09-01

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with newly diagnosed, previously untreated acute leukemia and malignant lymphoma.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with written consent of the study.

Exclusion criteria

Exclusion criteria: Patients who could not obtain written consent.

Design outcomes

Primary

Measure	Time frame
The association of serum soluble LR11 level at diagnosis and complete response rate.	—

Secondary

Measure	Time frame
The association of serum soluble LR11 level and recurrence rate, overall survival rate, and disease free survival rate. The association of serum soluble LR11 levels and previously known predictive markers.	—

Countries

Japan,Europe

Contacts

Public ContactChikako Ohwada

Department of Clinical Cell Biology, Division of Hematology

chikako_ohwada@faculty.chiba-u.jp043-225-6502

Outcome results